Medical Marketing and Media published an article recently stating that 46% of the highest-paid physicians (orthopedists at $413,000 annually) are unsatisfied with their pay. This is a telling metric given the discussions that compliance executives throughout the pharmaceutical industry are having around determining fair-market value (FMV) for the physicians their companies work with. Continue reading “Basing Fair-Market Value on Physicians’ Salary Data Isn’t Enough Anymore” »
When companies begin planning for national-level advisory board meetings, the first step is to delineate a clear objective and a set of goals. These stated aims will serve as useful reference points when recruiting for the meeting. They also allow for accountability — both internally for the organizers and externally for the participants — after the fact when companies look retrospectively at ad board activities. The most commonly recruited ad board members are specialists in their fields, although many companies are choosing to branch out into nursing and research fields for meeting participants.
Want to learn more about Pharmaceutical Advisory Boards? Then please join Cutting Edge Information’s Lead Research Analyst Jacob Presson at CBI’s “Life Sciences Advisory Board Strategy and Efficiency Summit” on April 28th in San Francisco, CA. Mr. Presson will be on hand to discuss the key points of this infographic.
Continue reading “[Infographic] Pharmaceutical Advisory Board Recruiting Strategy” »
By Christie Shilling,
I play video games often in my free time and hold a particular love for the Portal series. At the end of the first game, there is a cute song that contains the line, “We do what we must because we can.” There aren’t many similarities I can find between pharma and the fictional Aperture Science company from the games (pending any news regarding armies of mantis men). But that particular line lies parallel to the situation in which many companies find themselves as the digital age continues to bloom. Medical publications transparency, in particular, is one area in which several companies are only beginning to actually do what they must. Continue reading “The Demand for and Implementation of Medical Publications Transparency” »
Cutting Edge Information’s recent research in pharma sales force management reveals that the cost per sales rep has remained fairly consistent over the past several years. Despite this consistency, the way in which the sales force is compensated fluctuates fairly often. Companies continually adjust base pay, bonus packages, qualifications for bonuses, and other elements of compensation in pursuit of the elusive perfect payment plan. Modifying the compensation plan can help companies develop better practices and change with a product line. Continue reading “Four Simple Rules for Compensating Your Pharma Sales Force” »
Phase I clinical trials are supposed to be the quickest, easiest trials with the simplest question in mind: will the drug harm the patient? No? Good, then you may proceed. However, sometimes the trials are not as straightforward as all that – there can be problems in recruiting, sites can drop out, etc. For many companies, a good way to expedite Phase I trials – and save a little money – is to use contract research organizations (CROs) to administer the trial. In fact, surveyed drug companies outsource 70% of Phase I trial costs. Continue reading “Selecting the Right Vendor for Phase I Clinical Trials: Preferred Provider List or Bidding Process?” »
When bringing together a group of active clinicians and specialists for a scientific advisory board, companies should make sure to maximize the effectiveness of the resources seated around the table. Each person in the room has a different set of experiences, all of which are invaluable to the clinical trial being discussed. The process of converting this aggregated knowledge into a better product is what differentiates an average advisory board from a truly successful one. Continue reading “Making the Most of Scientific Advisory Boards with Clear Objectives” »
As the life sciences industry grows, companies’ internal groups must also evolve to match changing demands. One surveyed pharmaceutical executive explained, “By and large, companies seem to know that consumers want more face time with organizations at a gut level, and companies are moving along that path.” In response to this movement, medical communications teams are experiencing increasing visibility within both medical affairs and life science companies at large. Continue reading “Looking Outside the Box: How Medical Communications Groups Engage the Medical Community” »
With the growth in companies’ pipelines, clinical trial management becomes essential. One aspect of study oversight, monitoring trial risk, has evolved in recent years. In traditional clinical studies, clinical research associates (CRAs) typically visit each investigative site every four to eight weeks. However, regularly scheduled visits are fairly uniform in nature and do not always consider site experience and level of patient enrollment — factors which could potentially define a site as being either higher or lower risk. Conceivably, under this type of structure, CRAs could visit sites that hadn’t enrolled a single patient — and do so with the same frequency as sites with high patient volumes. Continue reading “Clinical Trial Management: Risk-Based Monitoring Represents Viable Oversight Solution” »
By Christie Shilling,
Medical information teams serve not only as the central hub to which other functions can turn for scientific knowledge, but also as the primary contact center from which HCPs, pharmacists and patients can all receive unbiased information on the products they use. In order to further explore and benchmark practices in this area, Cutting Edge Information has launched a survey that focuses on the contact center aspect of medical information teams (See link below). Participants receive a slide deck of data on pharmaceutical call center outsourcing, structure and budget benchmarks, key performance indicators (KPIs) and strategy development. Continue reading “On the Lookout: Pharmaceutical Call Center Outsourcing, Performance Measurement and More!” »